Macquarie Group LTD Emergent Bio Solutions Inc. Transaction History

Macquarie Group LTD

  • $85.1 Billion
  • Q2 2024

A detailed history of Macquarie Group LTD transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 2,680 shares of EBS stock, worth $20,073. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,680
Holding current value
$20,073
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$1.86 - $6.98 $4,984 - $18,706
2,680 New
2,680 $18,000
Q3 2022

Nov 14, 2022
SELL
$20.09 - $35.8 $11,290 - $20,119
-562 Reduced 54.72%
465 $22,000
Q4 2021

Feb 11, 2022
SELL
$33.11 - $55.01 $844,139 - $1.4 Million
-25,495 Reduced 96.13%
1,027 $45,000
Q2 2021

Aug 13, 2021
BUY
$56.61 - $80.46 $107,615 - $152,954
1,901 Added 7.72%
26,522 $1.67 Million
Q1 2021

May 14, 2021
BUY
$86.23 - $125.19 $241,271 - $350,281
2,798 Added 12.82%
24,621 $2.29 Million
Q4 2020

Feb 16, 2021
BUY
$79.17 - $111.47 $184,307 - $259,502
2,328 Added 11.94%
21,823 $1.96 Million
Q3 2020

Nov 13, 2020
SELL
$81.91 - $134.94 $629,396 - $1.04 Million
-7,684 Reduced 28.27%
19,495 $2.01 Million
Q2 2020

Aug 11, 2020
SELL
$54.33 - $89.52 $53,406 - $87,998
-983 Reduced 3.49%
27,179 $2.15 Million
Q1 2020

May 15, 2020
SELL
$49.34 - $68.76 $208,658 - $290,786
-4,229 Reduced 13.06%
28,162 $1.63 Million
Q4 2019

Feb 14, 2020
BUY
$51.21 - $59.06 $146,255 - $168,675
2,856 Added 9.67%
32,391 $1.75 Million
Q3 2019

Nov 14, 2019
SELL
$40.6 - $57.2 $55,175 - $77,734
-1,359 Reduced 4.4%
29,535 $1.54 Million
Q2 2019

Aug 14, 2019
BUY
$39.92 - $53.86 $144,031 - $194,326
3,608 Added 13.22%
30,894 $1.49 Million
Q1 2019

May 15, 2019
BUY
$48.23 - $66.16 $173,628 - $238,176
3,600 Added 15.2%
27,286 $1.38 Million
Q4 2018

Feb 15, 2019
SELL
$55.63 - $73.24 $170,895 - $224,993
-3,072 Reduced 11.48%
23,686 $1.4 Million
Q3 2018

Nov 15, 2018
SELL
$52.05 - $66.51 $244,582 - $312,530
-4,699 Reduced 14.94%
26,758 $1.76 Million
Q2 2018

Aug 14, 2018
BUY
$48.33 - $55.64 $62,684 - $72,165
1,297 Added 4.3%
31,457 $1.59 Million
Q1 2018

May 11, 2018
SELL
$44.44 - $54.39 $394,049 - $482,276
-8,867 Reduced 22.72%
30,160 $1.59 Million
Q4 2017

Feb 15, 2018
SELL
$37.77 - $47.75 $96,162 - $121,571
-2,546 Reduced 6.12%
39,027 $1.81 Million
Q3 2017

Nov 08, 2017
BUY
$34.14 - $40.45 $1.42 Million - $1.68 Million
41,573
41,573 $1.68 Million

Others Institutions Holding EBS

# of Institutions
154
Shares Held
30.2M
Call Options Held
137K
Put Options Held
706K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $373M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email